drug-eluting News

The coronary stents market is dominated by drug-eluting stents, but the market for anti-restenosis has proven dynamic due to many active companies with diverse technologies targeting this area of cardiovascular treatment.

The global coronary stent market faces continued growth, development and competition from a wide range of technology types and competitors. The market is detailed in a new report from MedMarket Diligence.

Coronary artery disease treatments have faced a succession of new technology solutions that have led to the large, but now competitive drug-eluting stents market, but the success of developments continues with more challenges and opportunities.

The market for coronary stents worldwide is well established, large and still demonstrating excellent growth, especially with the advent of new technologies from established and hopeful competitors, according to a new report from MedMarket Diligence.

Coronary artery disease is addressed by a range alternative treatment methodologies; percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other options, but stents represent the fastest growing option.